Skin & Allergy News

View more issues:

Articles in May, 2008 issue of Skin & Allergy News

• Atopy's rise in kids keeps center busy
  by Doug Brunk
• Blood test is no longer required for dapsone gel: phase IV safety study behind FDA decision
  by Bruce Jancin
• Insurance drug tiers slap heavy burden on patients
  by Mary Ellen Schneider
• Predicted increase in the global market for prescription dermatologic drugs
• New members welcomed to editorial advisory board
• Tanning industry challenge disputes melanoma evidence
  by Alicia Ault
• Sunscreen chemical "widespread" in U.S. population
  by Molly Laas
• Academy members elect new leadership for 2009
  by Mary Ellen Schneider
• Diet gains legitimacy as potential factor in acne
  by Bruce Janchin
• Laser more cost effective than drugs for rosacea, study finds
  by Jeff Evans
• Over-the-counter drugs may improve erythema in rosacea
  by Betsy Bates
• Artiss, Arcalyst
  by Elizabeth Mechcatie
• Infection at MRI ups risk for NSF, analysis finds
  by Kerri Wachter
• Survival rates worse for scalp/neck melanoma
  by Michele G. Sullivan
• Rose Hirschler award recipient announced
• Lymph node dissection overlooked in melanoma: complete dissection was performed in 1,470 of 2,942 patients with a positive biopsy, data show
  by Patrice Wendling
• Female melanoma survival advantage extends to children
  by Patrice Wendling
• Patient advocates make good partners
  by Jennifer Sweeney
• Take your medicine
  by Alan Rockoff
• Laser lipolysis: the future of liposuction
  by Robert A. Weiss
• When to consider using efalizumab for psoriasis
  by Bruce Jancin
• Expert examines appropriate role for alefacept in psoriasis
  by Bruce Jancin
• Pulsed dye laser may clear some chronic, resistant psoriatic lesions
  by Sharon Worcester
• Genetic variations link psoriasis, psoriatic arthritis
  by Jane Salodof MacNeil
• Mixed results for limb infusion in melanoma
  by Patrice Wendling
• Melanoma researchers turn to targeted inhibition
  by Bruce Jancin
• BCC responds to hedgehog signal suppression
  by Betsy Bates
• 'Ugly duckling' melanoma screen is easy, effective
  by Bruce Jancin
• Excision guideline compliance improves outcome
  by Patrice Wendling
• Don't cede early-stage mycosis fungoides
  by Joan Guitart
• Add points for mycosis fungoides Dx
  by Bruce Jancin
• Unifying term proposed for T-cell clonality diseases
  by Bruce Jancin
• Mahonia
  by Leslie S. Baumann
• Laser lipolysis beats liposuction in two studies
  by Sharon Worcester
• Combo treatment improves body contouring outcomes
  by Sharon Worcester
• Deep filler injections tackle aging bone structure
  by Carolyn Sachs
• Follow-up study finds calcium hydroxylapatite safe at 4 years
  by Greg Muirhead
• Eye shield use during laser procedures strongly advised
  by Carolyn Sachs
• Progress lacking in vaginal microbicide research
  by Michele G. Sullivan
• Early syphilis often missed in HIV-positive men
  by Nancy Walsh
• Azithromycin-resistant T. pallidum strains on rise in San Francisco
  by Michele G. Sullivan
• Single-dose drug matches penicillin for syphilis Tx
  by Michele G. Sullivan
• Universal MRSA screening slashes rates by half
  by Heidi Splete
• For second varicella dose, earlier may be better
  by Ilya Petrou
• Cervarix offers long-term protection against HPV
  by Sharon Worcester
• Genital herpes: what patients might not know
  by Diana Mahoney
• Experimental HPV vaccine shows promise
  by Sharon Worcester
• Pemphigoid, calciphylaxis care go off label
  by Bruce Jancin
• From A to V, more off-label skin disease therapies suggested
  by Bruce Jancin
• Cryotherapy wounds healed without topical antibiotic use
  by Bruce Jancin
• Hailey-Hailey disease rarity results in delayed diagnosis
  by Betsy Bates
• Omalizumab therapy found to quell symptoms of urticaria, food allergy
  by Mitchel L. Zoler
• L. rhamnosus intake decreased eczema risk
  by Robert Finn
• Sustained benefits seen with anti-TNFs in PsA
  by Nancy Walsh
• HGH prescribing requires 'thoughtful approach'
  by Mary Ellen Schneider
• Preemptive steroids could prevent lupus flare
  by Nancy Walsh
• Consider antimalarials 'first-line therapy' for lupus, expert says
  by Bruce Jancin
• New topical and systemic lupus therapies in pipeline
  by Bruce Jancin
• Seasonal allergies may be linked to depression
  by Mitchel L. Zoler
• Women with depression found to be more sensitive to general anesthesia
  by Sherry Boschert
• New documentary addresses high physician suicide risk
  by Greg Muirhead
• Botox injections relieve pain of plantar fasciitis
  by Fran Lowry
• Smoking may raise risk of developing neuropathic pain
• Pain rehabilitation programs reduce costs of medication
• Charter sets rules for physician report cards
  by Mary Ellen Schneider
• Congress to AMA: long-term SGR solution unlikely this year
  by Joel B. Finkelstein
• Market swing to noninjectables?
  by Alicia Ault
• NSF-gadolinium cases centralized
  by Alicia Ault
• QLT to divest Aczone
  by Alicia Ault
• Judge rules for journals
  by Alicia Ault
• Trouble paying for Rx
  by Alicia Ault
• Advocates call SCHIP enrollment data misleading
  by Alicia Ault
• Dermatologist relishes cameo roles
  by Doug Brunk
• Are Wi-fi, latte, and e-mail physician marketing tools of the future?
  by Betsy Bates
• Military strives for better coordination of care
  by Joel B. Finkelstein
• Alopecia patients can get support online
• Health reform possible even in slowing economy
  by Joyce Frieden
• Hospital compare web site gives patients a voice
  by Joyce Frieden
• Is your overhead too low?
  by Joseph S. Eastern
• MedPAC looks at hospitalists' recent growth
  by Alicia Ault

• 1
• 2